Valona Named as a Leader in the 2026 Gartner® Magic Quadrant™ for Competitive and Market Intelligence Platforms! 🏆

Read more
LEADER, 2026 GARTNER® MAGIC QUADRANT™ FOR COMPETITIVE AND MARKET INTELLIGENCE PLATFORMS

Pharma market intelligence for competitive and strategy teams

Valona is a competitive and market intelligence platform that helps pharma teams spot competitor readouts, regulatory decisions, deals and pricing shifts early, while there’s time to shape portfolio, launch and partnering decisions.

What questions can pharma intelligence and strategy teams answer with Valona?

The questions that come up in launch, pricing and deal discussions, and what Valona tracks to help answer them.

  • Which competitor moves could change my plans this quarter?

    Track competitor launches, FDA and EMA approvals, partnerships and late-stage trial readouts in your therapy areas, including news that first appears in local-language sources, summarized in English.

  • Check detail icon pine

    How are drug pricing reforms reshaping my market?

    Follow Medicare drug price negotiation under the IRA, most-favored-nation pricing and the EU pharma package as they unfold, with analysis of what they means for launch and market access.

  • Who is acquiring, licensing and partnering in pharma, and what are they after?

    Follow biotech acquisitions, licensing deals and partnerships in your areas, including the growing number of Chinese-originated assets licensed to Western pharma, often reported first in Chinese-language media.

  • Where are competitors building capacity, and where could supply break?

    Track new plants, CDMO and capacity investments, US onshoring, and the drug shortages reported by regulators across Europe and Asia.

  • What are pharma competitors signaling to investors?

    Compare earnings results, guidance and portfolio commentary alongside validated financials, with Valona’s earnings analyses highlighting shifts in priorities.

  • What will my therapy areas look like in three years?

    See which new mechanisms, drug classes and business models are gaining ground, with trend radars and AI-powered research for the areas you compete in.

Pharma market intelligence for your therapy areas

Whether you compete in obesity, oncology, rare diseases or cell and gene therapy, Valona sets up monitoring around your therapy areas, competitors and policy priorities, and follows the readouts, deals and policy shifts that matter there.

Valona intelligence platform

A market intelligence platform built for pharma decisions

Bring trial readouts, regulatory and pricing decisions, deals and competitor moves into one shared view.

Dashboards, alerts, newsletters and AI-generated analysis are built around your therapy areas and competitors, with every insight linked to its source, so brand, market access and leadership teams can see what’s changing and why it matters.

GLOBAL SOURCE COVERAGE

Pharma intelligence from global and local sources

The developments that matter often surface first in a regulator’s update or a local-language report. Valona monitors 900+ specialist pharma and trade sources within a global base of 200,000+ sources in 115+ languages. That often means seeing a story in Chinese, Danish, German or Korean media before international press picks it up, summarized in English for your team.

If a source your team relies on is missing, Valona’s source team can add it.

COMPETITOR ANALYSIS TOOL

Pharma competitor analysis, backed by validated financials

Valona’s competitor profiles bring together each rival’s news, filings, deals and earnings, alongside validated financial profiles and Valona’s earnings analyses for listed companies. Your team can see where competitors are putting investment, what they’re telling investors and which therapy areas they’re prioritizing, with news on the assets you follow grouped in one place.

PIPELINE MONITORING

Track the competitor programs that matter to you

Valona monitors competitor pipeline news, from trial readouts and filings to regulatory decisions, and organizes it by therapy area, mechanism and drug. When a trial stops early, misses an endpoint or a filing is delayed, you see it alongside the rest of the competitive picture, and your team and Valona’s analysts can work through what it means for your plans. For the programs you choose, Valona’s analysts can also build pipeline trackers that follow them stage by stage.

Why pharma teams choose Valona

An intelligence partner, not just a platform

  • Setup around your structure

    A solution consultant builds dashboards and alerts around how your business is organized: your competitors, products, therapy areas and regulatory priorities.

  • Check detail icon pine

    Ongoing support

    A customer success manager helps your stakeholders get value from the platform as your priorities change.

  • Regular analyst reviews

    Valona analysts synthesize what’s changed in your market, timed to your planning cycle.

  • Research and analysis

    Support for ad hoc questions, plus competitor landscapes, policy impact briefings and trend radars scoped to your more specialized needs. Power users can also adjust dashboards and alerts themselves.

Frequently asked questions about pharma market intelligence

Pharma market intelligence is the ongoing collection and analysis of information about competitors, therapy areas, regulation and market conditions in the pharmaceutical industry. It covers developments such as trial readouts, regulatory decisions, launches, deals, pricing and access policy, and loss of exclusivity.

Its purpose is to help strategy, commercial, business development and portfolio teams understand how their market is changing and what that means for their decisions. Competitive intelligence is the part focused specifically on competitors.

Pharmaceutical companies use competitive intelligence to follow competitor programs and launches, anticipate threats to their products, and plan launch and lifecycle strategy ahead of loss of exclusivity. It also supports business development: as more pipelines are refilled through licensing and acquisitions, including a growing share of assets from China, teams need to know which assets and companies are attracting deals. Market access teams use it to follow pricing and HTA decisions across countries. Strategy teams use it to test assumptions about competition, timelines, pricing and access before committing resources.

Intelligence is often shared around key moments such as congresses, trial readouts, regulatory decisions and earnings seasons, when the competitive picture can change quickly.

Look at five things: coverage of global, local-language and licensed sources beyond major English-language news; relevance, with monitoring scoped to your competitors, therapy areas and markets; traceability, so every insight links back to its source; analysis that explains what a development means, not just that it happened; and delivery through alerts, newsletters, dashboards and connections to your AI tools.

Valona is built around these needs, combining a competitive and market intelligence platform with analyst support from Valona’s team.

Pharmaceutical companies monitor competitors by tracking trial readouts, regulatory milestones such as NDA/BLA and MAA filings, PDUFA dates and CHMP opinions, launches and labels, partnerships, acquisitions, leadership changes and financial results. Doing this manually means checking many sources and keeping internal trackers up to date.

A competitive intelligence platform such as Valona brings these developments into structured competitor profiles and timely alerts. That gives your team time to investigate what a move means instead of searching for it.

Yes. Valona monitors competitor pipeline news, from trial readouts to regulatory decisions, and can organize it by therapy area, mechanism and drug so news on a competitor’s assets comes together in one place. Valona’s analysts also build pipeline trackers for customers, in several formats depending on what the team needs.

Clinical trial and pipeline databases such as Cortellis, Evaluate Pharma and Citeline are systems of record: they tell you what is in development. Valona is the intelligence layer around them. It monitors regulator announcements and global business, trade and local-language press, links each development to your competitors and therapy areas, and uses AI and Valona’s analysts to explain what it means.

Valona works alongside these databases, not instead of them, and can bring your existing subscriptions into the same platform, subject to licensing.

Yes. Valona covers both industries, so your team can follow developments where they meet. For example, GLP-1 drugs could change demand for sleep apnea devices and bariatric surgery. See our medical devices intelligence.

What’s your next move in pharma?

Planning a launch, preparing for loss of exclusivity, weighing an in-licensing deal or adjusting to pricing reform? Tell us what you’re working on, and we’ll show you how Valona can help you sharpen the recommendations you take to leadership.